Notably, CD2high T cells demonstrated pronounced increases in activation marker expression upon encountering tumor cells, whereas T cell activation levels were lower in CD2inter T cells and became minimal in CD2low T cells (Figures 3C and S3C), aligning with the critical role of the CD58 -CD2 pathway in T cell activation.17,27,29–31. The gene discussed is CD2; the disease is neoplasm.